Diligence memo · auto-generated · as of July 2, 2026

Aspen Aerogels Inc

Aspen Aerogels Inc looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Aspen Aerogels Inc operates in Other Technology, based in NORTHBOROUGH.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Aspen Aerogels Inc has raised $323M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $100M on 2022-02-18.

Most recent recorded round closed around 2022-03-28.

Valuation (modeled)modeled

Provath models Aspen Aerogels Inc at approximately $928M (range $189M–$1.9B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.39× the median modeled value of Series C Other Technology companies in 2022–2024 (187 peers) — value vs value, same stage and era. Within the normal band (139% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 14 months.

Last raise 4.3 yr ago; this sector typically re-raises about every 13 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 99% of Other Technology peers (21302 compared).

Modeled value ranks above 96% of those peers.

Closest niche peers: LinkSquares, Inc., Semperis Ltd., Veev Group, Inc., GPI Acquisitions, Inc., DVX Ventures LLC.

Peoplefiled

24 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.